Your browser doesn't support javascript.
loading
Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.
Qiu, Yongxin; Dai, Yi; Zhang, Chi; Yang, Ye; Jin, Ming; Shan, Wenqi; Shen, Jian; Lu, Ming; Tang, Zhaoyang; Ju, Liang; Wang, Yuting; Jiao, Ruonan; Xia, Yunwei; Huang, Guangming; Yang, Lihua; Li, Yuan; Zhang, Jianping; Wong, Vincent Kam Wai; Jiang, Zhihong.
Afiliación
  • Qiu Y; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Dai Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhang C; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China.
  • Yang Y; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Jin M; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Shan W; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Shen J; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Lu M; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Tang Z; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Ju L; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang Y; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Jiao R; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Xia Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Huang G; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Yang L; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li Y; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang J; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China. liyuan@njmu.edu.cn.
  • Wong VKW; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China. liyuan@njmu.edu.cn.
  • Jiang Z; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. zjpnjmu@aliyun.com.
J Exp Clin Cancer Res ; 37(1): 321, 2018 Dec 20.
Article en En | MEDLINE | ID: mdl-30572915
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Carcinoma Hepatocelular / Proteínas 14-3-3 / Trióxido de Arsénico / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Carcinoma Hepatocelular / Proteínas 14-3-3 / Trióxido de Arsénico / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido